D.-W. Kim

3k citations
60 papers · 2.4k · 3 hit papers · h-index 18

Impact in

    • Lung Cancer Treatments and Mutations
    • Brain Metastases and Treatment
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • HER2/EGFR in Cancer Research

Papers in

D.-W. Kim

59 papers receiving 2.3k citations

D.-W. Kim's Hit Papers

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial 2022 · 137 citations
1370+3+6Years since publication100200300400

Peers

D.-W. Kim
Comparison fields: 5 of 69
  • Pulmonary and Respiratory Medicine 1.6k
  • Oncology 531
  • Cancer Research 73
  • Economics and Econometrics 58
  • Toxicology 10
Replace Martin Neil Reaume with:
Martin Neil Reaume Canada
Francis X. Parnis Australia
Nicola Jane Lawrence Australia
Roberto Massimo Carlesi Italy
Alessandro Del Conte Italy
Joshua H. Zhang United States
Chanchal Goswami India
Taro Iguchi Japan
Oana Petrenciuc United States
Martin Eduardo Richardet United States
D.-W. Kim relative to Martin Neil Reaume Canada Martin Neil Reaume's profile →
Citations per field
00.5×1.5×2×2.4×
Martin Neil Reaume · 1×
Citations per year

Countries citing papers authored by D.-W. Kim

Since Specialization
Citations

This map shows the geographic impact of D.-W. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.-W. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.-W. Kim more than expected).

Fields of papers citing papers by D.-W. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.-W. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.-W. Kim. The network helps show where D.-W. Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside D.-W. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D.-W. Kim Line = papers co-authored together D.-W. Kim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study
Hit paper breakdown →
2020496
2
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
Hit paper breakdown →
2017439
3 2021231
4 2014191
5
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
Hit paper breakdown →
2022137
6 2015114
7 201986
8 202071
9 201660
10 201637
11 202437
12 201936
13 201635
14 201829
15 201925
16 201925
17 201924
18 202022
19 201618
20 201817

About D.-W. Kim

D.-W. Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Orthopedics and Sports Medicine, Nephrology and Ophthalmology, having authored 60 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (49 papers), Cancer Immunotherapy and Biomarkers (11 papers), Bone health and osteoporosis research (1 paper), Drug-Induced Ocular Toxicity (1 paper), Fibroblast Growth Factor Research (1 paper), Acute Kidney Injury Research (1 paper), Brain Metastases and Treatment (1 paper) and Hip and Femur Fractures (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Oncology (531 citations), Cancer Research (73 citations), Economics and Econometrics (58 citations) and Toxicology (10 citations). D.-W. Kim has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include Tony S.K. Mok, Sai‐Hong Ignatius Ou, Alice Tsang Shaw, D. Ross Camidge, Shirish M. Gadgeel, Walter Bordogna, Vlatka Smoljanović, Solange Peters, Rafał Dziadziuszko and Magalie Hilton. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer, Osteoporosis International and Transplantation Proceedings.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact